Delivery Order SPE2DB24D3015-SPE2DB25FFZLC
Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,361.02 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mesalamine 400 mg capsules (180-count units). This non-set-aside contract features firm fixed pricing and is scheduled for completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $14,506.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 1.2GM (120 count) with an ultimate completion date of October 15, 2025. The award, issued on September 17, 2025, was competitively awarded with no set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,879.92 contract is for the supply of 180 count capsules of the drug Mesalamine DR 400 mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,412.14 contract is for the delivery of 180 tablets of 800 mg mesalamine delayed-release medication. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $10,411.70. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and...
- The Defense Logistics Agency awarded a $1,724.60 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count). The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not set aside for any particular business category and was competitively awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count) under a firm fixed-price contract. The order, valued at $40,028.47, is scheduled for completion by April 28, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- This federal contract award is for the delivery of 180 capsules of Mesalamine DR 400 mg, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA). The $4,386.03 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Mesalamine DR 400 mg capsules. The $1,918.44 firm-fixed-price contract has an ultimate completion date of September 19, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
- The Defense Logistics Agency awarded a $4,252.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count). This non-set-aside, competitively awarded contract is scheduled for completion by September 18, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...